Cell-free fetal DNA screening for detection of microdeletion syndromes: A cost-effectiveness analysis

被引：0
|
作者：
Avram, Carmen M. [1 ]
Shaffer, Brian L. [1 ]
Sparks, Teresa N. [2 ]
Allen, Allison J. [1 ]
Caughey, Aaron B. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2019年 / 220卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2018.11.909
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
885
引用
收藏
页码：S575 / S575
页数：1
相关论文
共 50 条
  • [31] Early detection of cell-free fetal DNA in maternal plasma
    Illanes, S.
    Denbow, M.
    Kailasam, C.
    Finning, K.
    Soothill, P. W.
    EARLY HUMAN DEVELOPMENT, 2007, 83 (09) : 563 - 566
  • [32] Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness Analysis
    Zelner, Irene
    Koren, Gideon
    THERAPEUTIC DRUG MONITORING, 2009, 31 (02) : 170 - 172
  • [33] Universal or targeted screening for fetal alcohol exposure: A cost-effectiveness analysis
    Hopkins, Robert B.
    Paradis, Jon
    Roshankar, Tozheg
    Bowen, James
    Tarride, Jean-Eric
    Blackhouse, Gord
    Lim, Morgan
    O'Reilly, Daria
    Goeree, Ron
    Longo, Christopher J.
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2008, 69 (04) : 510 - 519
  • [34] Current Status of Testing for Microdeletion Syndromes and Rare Autosomal Trisomies Using Cell-Free DNA Technology
    Yaron, Yuval
    Jani, Jacques
    Schmid, Maximilian
    Oepkes, Dick
    OBSTETRICS AND GYNECOLOGY, 2015, 126 (05): : 1095 - 1099
  • [35] The price of abandoning diagnostic testing for cell-free fetal DNA screening
    Evans, Mark I.
    Evans, Shara M.
    Bennett, Terry Ann
    Wapner, Ronald J.
    PRENATAL DIAGNOSIS, 2018, 38 (04) : 243 - 245
  • [36] i Cell-free DNA screening for fetal aneuploidy as a clinical service
    Cuckle, Howard
    Benn, Peter
    Pergament, Eugene
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 932 - 941
  • [37] Fetal and neonatal outcomes after "atypical findings" on cell-free fetal DNA screening
    Mei, Jenny Y.
    Murali, Aparna
    Nitka, Alexa
    Kang, Sung-Hae
    Saitta, Sulagna C.
    Han, Christina S.
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (08)
  • [38] False negative fetal cell free DNA screening for microdeletion syndromes in the presence of an unbalanced translocation involving monosomy 4p
    Qi, Zhongxia
    Madaan, Shreshtha
    Chetty, Shilpa
    Yu, Jingwei
    Wiita, Arun P.
    PRENATAL DIAGNOSIS, 2017, 37 (04) : 420 - 422
  • [39] Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis
    Gil, M. M.
    Quezada, M. S.
    Revello, R.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (03) : 249 - 266
  • [40] Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening test
    Blanquet, Marie
    Dreux, Sophie
    Leger, Stephanie
    Sault, Corinne
    Mourgues, Charline
    Laurichesse, Helene
    Lemery, Didier
    Vendittelli, Francoise
    Debost-Legrand, Anne
    Muller, Francoise
    ANNALES DE BIOLOGIE CLINIQUE, 2021, 79 (04) : 331 - 344
12345